Arterra Bioscience S.p.A. (BIT:ARBS)
 3.080
 +0.020 (0.65%)
  Nov 3, 2025, 12:31 PM CET
Arterra Bioscience Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
 Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year  | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2017 - 2019 | 
|---|---|---|---|---|---|---|
Period Ending  | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2017 - 2019 | 
Cash & Equivalents     | 3.34 | 3.69 | 4.39 | 4.81 | 4.54 | Upgrade   | 
Trading Asset Securities     | - | - | 1.6 | - | - | Upgrade   | 
Cash & Short-Term Investments     | 3.34 | 3.69 | 5.99 | 4.81 | 4.54 | Upgrade   | 
Cash Growth     | -9.29% | -38.48% | 24.46% | 6.13% | -2.85% | Upgrade   | 
Accounts Receivable     | 1.63 | 1.06 | 0.77 | 1.47 | 1.06 | Upgrade   | 
Other Receivables     | 1.98 | 1.78 | 1.88 | 1.71 | 1.63 | Upgrade   | 
Receivables     | 3.61 | 2.84 | 2.65 | 3.19 | 2.69 | Upgrade   | 
Inventory     | 1.33 | 1.36 | 1.16 | 0.49 | 0.57 | Upgrade   | 
Other Current Assets     | 0 | 0 | 0 | 0 | 0 | Upgrade   | 
Total Current Assets     | 8.29 | 7.89 | 9.81 | 8.49 | 7.8 | Upgrade   | 
Property, Plant & Equipment     | 1.51 | 1.23 | 1.54 | 1.66 | 1.4 | Upgrade   | 
Long-Term Investments     | 3.45 | 3.35 | 0.98 | 0.95 | 0.45 | Upgrade   | 
Other Intangible Assets     | 0.03 | 0.04 | 0.05 | 0.13 | 0.1 | Upgrade   | 
Long-Term Deferred Charges     | 0 | - | 0.15 | 0.31 | 0.46 | Upgrade   | 
Other Long-Term Assets     | 0.11 | 0.04 | 0.04 | 0.04 | 0.11 | Upgrade   | 
Total Assets     | 13.4 | 12.55 | 12.57 | 11.58 | 10.32 | Upgrade   | 
Accounts Payable     | 0.28 | 0.25 | 0.19 | 0.25 | 0.19 | Upgrade   | 
Accrued Expenses     | 0.31 | 0.43 | 0.32 | 0.69 | 0.58 | Upgrade   | 
Current Portion of Long-Term Debt     | 0.1 | 0.09 | 0.17 | 0.22 | 0.22 | Upgrade   | 
Current Income Taxes Payable     | - | - | 0.23 | 0.02 | - | Upgrade   | 
Other Current Liabilities     | 0.14 | 0.08 | 0.24 | 0.05 | 0.05 | Upgrade   | 
Total Current Liabilities     | 0.82 | 0.84 | 1.16 | 1.23 | 1.03 | Upgrade   | 
Long-Term Debt     | 0.26 | 0.3 | 0.32 | 0.39 | 0.59 | Upgrade   | 
Long-Term Deferred Tax Liabilities     | 0.38 | 0.22 | 0.24 | 0.2 | 0.15 | Upgrade   | 
Other Long-Term Liabilities     | 0.52 | 0.44 | 0.39 | 0.29 | 0.37 | Upgrade   | 
Total Liabilities     | 1.98 | 1.8 | 2.1 | 2.11 | 2.14 | Upgrade   | 
Common Stock     | 0.33 | 0.33 | 0.33 | 0.33 | 0.33 | Upgrade   | 
Additional Paid-In Capital     | 4.17 | 4.17 | 4.17 | 4.17 | 3.99 | Upgrade   | 
Retained Earnings     | 7.25 | 6.58 | 6.17 | 5.08 | 3.97 | Upgrade   | 
Treasury Stock     | -0.33 | -0.33 | -0.2 | -0.11 | -0.11 | Upgrade   | 
Shareholders' Equity     | 11.42 | 10.75 | 10.47 | 9.47 | 8.18 | Upgrade   | 
Total Liabilities & Equity     | 13.4 | 12.55 | 12.57 | 11.58 | 10.32 | Upgrade   | 
Total Debt     | 0.36 | 0.39 | 0.49 | 0.61 | 0.81 | Upgrade   | 
Net Cash (Debt)     | 2.99 | 3.3 | 5.5 | 4.2 | 3.73 | Upgrade   | 
Net Cash Growth     | -9.48% | -40.03% | 31.02% | 12.69% | 1.62% | Upgrade   | 
Net Cash Per Share     | 0.45 | 0.50 | - | - | - | Upgrade   | 
Filing Date Shares Outstanding     | 6.66 | 6.66 | - | - | - | Upgrade   | 
Total Common Shares Outstanding     | 6.66 | 6.66 | - | - | - | Upgrade   | 
Working Capital     | 7.47 | 7.04 | 8.65 | 7.26 | 6.77 | Upgrade   | 
Book Value Per Share     | 1.72 | 1.61 | - | - | - | Upgrade   | 
Tangible Book Value     | 11.39 | 10.71 | 10.42 | 9.34 | 8.08 | Upgrade   | 
Tangible Book Value Per Share     | 1.71 | 1.61 | - | - | - | Upgrade   | 
Land     | 1.09 | 0.72 | 0.72 | 0.61 | 0.61 | Upgrade   | 
Machinery     | 2.57 | 2.43 | 2.41 | 2.61 | 2.06 | Upgrade   | 
Construction In Progress     | 0.01 | - | - | 0.01 | - | Upgrade   | 
Source: S&P Global Market Intelligence. Standard template. Financial Sources.